STAT | Reporting from the frontiers of health and medicine

Opinion: CMS shouldn’t be paying for higher-than-necessary doses of cancer drugs

In cancer treatment, higher doses with worse side effects often don’t lead to better outcomes.
favicon
statnews.com
statnews.com
Image for the article: Opinion: CMS shouldn’t be paying for higher-than-necessary doses of cancer drugs
Create attached notes ...